Issue of Equity & TVR

RNS Number : 1480B

Alpha Growth PLC

05 June 2019

 

Alpha Growth plc
("Alpha, or the "Company")

Issue of Equity & TVR

Alpha Growth plc (LSE: ALGW), the financial services specialist in the growing Senior Life Settlement ("SLS") asset class, announces that it has today issued 1,666,666 new ordinary shares of 0.1 pence each in the Company, valued at the last placing price of 1.5 pence per new share, to Novum Securities Limited ("Novum"). The issuance of shares to Novum represents their annual retention fees, net of VAT which Alpha has paid to Novum in cash, to act as the company's Broker. The new shares will, when issued, rank pari passu in all respects with the existing ordinary shares. An application will be made for the new shares to be admitted to trading and admission is expected to take place on or around 5 June 2019 ("Admission").

On Admission the Company's issued share capital will consist of 158,701,666 ordinary shares. The Company does not hold any Ordinary Shares in Treasury. The total voting rights from Admission will therefore be 158,701,666  shares. This figure above may be used by shareholders as from 6 June 2019 as the denominator for the calculations by which they determine if they are required to notify their interest in, or change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

For more information, please visit www.algwplc.com or contact the following:

Alpha Growth plc	[phone]
Gobind Sahney, Executive Chairman	[e-mail]
Novum Securities Limited (Corporate Broker)	[phone]
Colin Rowbury	[e-mail]

About Alpha Growth plc
Specialist in Longevity Assets
Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, Alpha Growth has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Company's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide wholistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.
 

 

END

 

 

IOEDMGGVRDRGLZM